We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+10.2%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$1.08T
AUM Growth
+$79.9B
Cap. Flow
-$8.94B
Cap. Flow %
-0.83%
Top 10 Hldgs %
25.7%
Holding
3,000
New
159
Increased
1,164
Reduced
1,499
Closed
84

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.45B
2
PINS icon
Pinterest
PINS
+$1.89B
3
TMUS icon
T-Mobile US
TMUS
+$1.89B
4
ZM icon
Zoom
ZM
+$1.77B
5
PATH icon
UiPath
PATH
+$1.71B

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$3.66B
2
CAT icon
Caterpillar
CAT
+$1.32B
3
NFLX icon
Netflix
NFLX
+$1.18B
4
MXIM
Maxim Integrated Products
MXIM
+$1.15B
5
MU icon
Micron Technology
MU
+$1.07B

Sector Composition

Rank Sector Weight
1 Technology 24.62%
2 Healthcare 16.07%
3 Consumer Discretionary 15.29%
4 Communication Services 13.46%
5 Financials 12.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
USPH icon
651
US Physical Therapy
USPH
$1.23B
$149M 0.01%
1,288,061
-12,826
-1% -$1.47M
RCKT icon
652
Rocket Pharmaceuticals
RCKT
$366M
$148M 0.01%
3,352,685
-246,150
-7% -$10.7M
DLO icon
653
dLocal
DLO
$4.33B
$148M 0.01%
+2,822,799
New +$109M
MSEX icon
654
Middlesex Water
MSEX
$1.11B
$148M 0.01%
1,807,736
+9,864
+0.5% +$817K
RDS.B
655
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$147M 0.01%
3,797,617
-30,312
-0.8% -$1.14M
VRTS icon
656
Virtus Investment Partners
VRTS
$1.12B
$147M 0.01%
530,176
+5,338
+1% +$1.44M
BECN
657
DELISTED
Beacon Roofing Supply, Inc.
BECN
$147M 0.01%
2,752,774
-88,805
-3% -$4.96M
RDUS
658
DELISTED
Radius Health, Inc.
RDUS
$145M 0.01%
7,970,176
+15,891
+0.2% +$316K
WB icon
659
Weibo
WB
$1.87B
$145M 0.01%
2,761,492
+197,224
+8% +$9.77M
NOV icon
660
NOV
NOV
$7.38B
$145M 0.01%
9,478,634
+1,310,604
+16% +$20.4M
VAC icon
661
Marriott Vacations Worldwide
VAC
$4.15B
$144M 0.01%
900,826
-237,156
-21% -$40.6M
DAL icon
662
Delta Air Lines
DAL
$60.2B
$143M 0.01%
3,309,345
+198,560
+6% +$9.19M
SHOO icon
663
Steven Madden
SHOO
$3.46B
$142M 0.01%
3,254,961
-294,990
-8% -$12.2M
WTW icon
664
Willis Towers Watson
WTW
$31B
$142M 0.01%
616,684
-1,753,647
-74% -$436M
MODV
665
DELISTED
ModivCare
MODV
$142M 0.01%
832,875
-1,646
-0.2% -$247K
TFC icon
666
Truist Financial
TFC
$64.8B
$141M 0.01%
2,545,179
-2,101,046
-45% -$123M
INDA icon
667
iShares MSCI India ETF
INDA
$6.58B
$141M 0.01%
3,191,800
+575,200
+22% +$24.7M
USB icon
668
US Bancorp
USB
$102B
$141M 0.01%
2,466,344
-48,223
-2% -$2.83M
BEKE icon
669
KE Holdings
BEKE
$18.6B
$140M 0.01%
2,932,179
+1,072,862
+58% +$54.8M
SRRK icon
670
Scholar Rock
SRRK
$6.59B
$139M 0.01%
4,820,037
+433,188
+10% +$13.3M
TWST icon
671
Twist Bioscience
TWST
$7.84B
$139M 0.01%
1,044,756
+86,849
+9% +$10.1M
BMRN icon
672
BioMarin Pharmaceuticals
BMRN
$13.3B
$139M 0.01%
1,660,316
-250,194
-13% -$19.8M
AL
673
DELISTED
Air Lease Corp
AL
$138M 0.01%
3,317,037
+646,278
+24% +$30M
OBK icon
674
Origin Bancorp
OBK
$1.68B
$138M 0.01%
3,251,461
-20,384
-0.6% -$884K
TPL icon
675
Texas Pacific Land
TPL
$23.9B
$138M 0.01%
773,748
+3,276
+0.4% +$570K

Similar funds

T. Rowe Price Associates's Q2 2021 Portfolio in Review

As of Q2 2021, T. Rowe Price Associates held 3,000 positions worth $1.08T, up 8% from $999B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

T. Rowe Price Associates's Q2 2021 filing shows 159 new, 1,164 increased, 1,499 reduced and 84 closed positions. Its largest new stake was UiPath: 23,377,090 shares worth $1.52B. The largest sale was Alibaba, an estimated $3.66B.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2021 buy was UiPath: 23,377,090 shares worth $1.52B.
  • T. Rowe Price Associates added most to Microsoft in Q2 2021, an estimated $3.45B increase.
  • T. Rowe Price Associates's biggest Q2 2021 reduction was Alibaba, cutting an estimated $3.66B.
  • T. Rowe Price Associates fully exited Pershing Square Tontine Holdings, Ltd. in Q2 2021, selling an estimated $145M.
  • T. Rowe Price Associates's ten largest holdings make up 26% of its $1.08T portfolio in Q2 2021.
  • T. Rowe Price Associates opened 159 new positions and closed 84 in Q2 2021.
  • T. Rowe Price Associates's portfolio value rose 8% quarter-over-quarter to $1.08T.

Based on T. Rowe Price Associates's 13F filing for Q2 2021, filed 16 Aug 2021.